ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1479	National Cancer Institute	Html	en	Prostate Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of prostate cancer.	prostate cancer warrants 0.499797 screen-detected prostate cancer 0.525488 grade prostate cancer 0.523426 Low-Risk Prostate Cancer 0.500547 Engl J Med 0.559367 advanced prostate cancer 0.529012 prostate cancer treatment 0.512803 Prostate Cancer Prostatic 0.498893 clinically localized prostate 0.673086 Int J Radiat 0.493888 metastatic prostate cancer 0.500485 Radiat Oncol Biol 0.568418 prostate cancer increases 0.499539 prostate specific antigen 0.536475 Natl Cancer Inst 0.689089 organ-confined prostate cancer 0.499295 radiation therapy 0.50488 Prostate cancer diagnosis 0.525315 prostate carcinoma 0.533902 et al. 0.579019 nonpalpable prostate cancer 0.508262 National Prostate Cancer 0.512122 Prostate Cancer section 0.509753 Prostate Cancer Outcomes 0.519033 recurrent prostate cancer 0.502138	castration-resistant prostate cancer 0.500277 prostate cancer eligible 0.506835 Prostate Cancer Intervention 0.504501 Prostate cancer radiation 0.50507 PUBMED Abstract 0.502954 radical prostatectomy 0.797797 Localized Prostate Cancer 0.557914 early prostate cancer 0.559358 Castration-Sensitive Prostate Cancer 0.498217 low grade prostate 0.495809 localised prostate cancer 0.501262 radical retropubic prostatectomy 0.495282 Abstract 0.672665 Clin Oncol 0.580989 Oncol Biol Phys 0.571819 prostate cancer prognosis 0.512411 Prostate Cancer Register 0.511523 prostate cancer survival 0.523146 risk prostate cancer 0.510212 prostate cancer 0.923001 Association Prostate Cancer 0.506382 prostate cancer progression 0.524034 prostate cancer recurrence 0.538252 watchful waiting 0.496685	CLICK HERE
1531	National Cancer Institute	Html	en	Childhood Ependymoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood ependymoma.	cancer treatment 0.626698 recurrent childhood ependymoma 0.554401 following PDQ summaries 0.501476 PDQ cancer information 0.603175 high-grade cancer cells 0.52438 clinical trial search 0.497636 brain tumors 0.624619 Childhood Ependymoma Treatment 0.537776 clinical trials 0.997686 Pediatric Treatment Editorial 0.517454 cancer information summary 0.560017 clinical trial 0.708531 anaplastic ependymoma 0.508455 patients 0.511213 NCI PDQ cancer 0.514722 brain stem 0.532471 radiation therapy 0.873758 Treatment Editorial Board 0.522486 treatment 0.865472 magnetic resonance imaging 0.501265 childhood ependymoma 0.915073 cancer cells 0.900504 standard treatment 0.509266 Cancer Information Service 0.497532 intensity-modulated radiation therapy 0.526143	PDQ Pediatric Treatment 0.501585 Conformal radiation therapy 0.512713 myxopapillary ependymoma 0.509213 treatment clinical trials 0.542772 National Cancer Institute 0.559542 spinal cord 0.912544 tumor cells 0.497383 effects cancer treatment 0.524938 proton-beam radiation therapy 0.524248 new treatment 0.578083 ependymoma forms 0.516544 childhood cancer information 0.507379 childhood brain tumors 0.536709 external radiation therapy 0.570552 treatment clinical trial 0.51013 brain 0.714551 PDQ summary 0.496378 RELA fusion–positive ependymoma 0.556789 cancer clinical trials 0.531786 tumor 0.709426 treatment options 0.516335 cancer information summaries 0.496292 comprehensive cancer information 0.49561 cancer 0.953861	CLICK HERE
1629	National Cancer Institute	Html	en	Penile Cancer Treatment (PDQ®)–Patient Version	Penile cancer is highly curable when found early. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for penile cancer.	cancer treatment 0.320382 biologic therapy 0.30297 Lymph node dissection 0.308565 tissue 0.393322 erectile tissue 0.338087 body 0.324795 PDQ cancer information 0.34528 clinical trial search 0.382837 Penile Cancer Treatment 0.305192 clinical trials 0.721694 cancer information summary 0.319238 clinical trial 0.569243 Recurrent penile cancer 0.32422 patients 0.29378 lymph node biopsy 0.446032 blood vessels 0.32868 sentinel lymph node 0.563667 spongy tissue 0.289271 treatment clinical trial 0.276059 NCI PDQ cancer 0.28258 lymph nodes 0.475166 radiation therapy 0.416871 General information 0.303882 general cancer information 0.275537 treatment 0.454305	wide local excision 0.318281 tumor cells 0.306254 new cancer treatments 0.275369 NCI-supported cancer 0.316489 cancer cells 0.48036 Cancer Information Service 0.276468 penile cancer 0.671625 connective tissue 0.347145 treatment clinical trials 0.301804 National Cancer Institute 0.364819 penis 0.345276 lymph vessels 0.289266 new treatment 0.324645 metastatic penile cancer 0.30082 cancer clinical trials 0.389935 stage 0.320852 tumor 0.326492 cancer information summaries 0.27434 comprehensive cancer information 0.27491 internal radiation therapy 0.325191 cancer 0.921282 information 0.35457 lymph ducts 0.299322 standard treatment 0.273177	CLICK HERE
1856	National Cancer Institute	Html	es	Tratamiento del cáncer de nasofaringe (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de nasofaringe.	recurrent nasopharyngeal carcinoma 0.314884 locoregionally advanced 0.32749 T-stage nasopharyngeal carcinoma 0.309795 advanced nasopharyngeal carcinoma 0.746023 nasopharyngeal cancer 0.331855 concurrent chemoradiotherapy 0.311059 advanced squamous 0.313322 randomized study 0.31172 Radiat Oncol Biol 0.67282 DeVita VT Jr 0.315434 randomized trial 0.419327 concurrent-adjuvant chemotherapy 0.32145 chemotherapy with radiotherapy 0.314748 Natl Cancer Inst 0.315479 randomized trial comparing 0.314639 treated with radiotherapy 0.309308 undifferentiated nasopharyngeal carcinoma 0.317213 patients with 0.383207 metastatic nasopharyngeal carcinoma 0.31503 radiation therapy 0.346053 carcinoma treated with 0.317616 with radiotherapy 0.334247 Tung SY 0.313347 Teo PM 0.315435 preliminary results 0.31387	eight randomized trials 0.309618 radiotherapy with 0.310444 nasopharyngeal carcinoma patients 0.31096 prospective randomized 0.316414 advanced undifferentiated carcinoma 0.309346 nasopharyngeal carcinoma 0.974941 Chan AT 0.318151 chemotherapy vs radiotherapy 0.31098 adjuvant chemotherapy with 0.312314 local control 0.310914 Clin Oncol 0.499014 Werning JW 0.309232 Oncol Biol Phys 0.70745 locally-advanced nasopharyngeal carcinoma 0.317916 primary nasopharyngeal carcinoma 0.309776 neck cancer 0.35727 American Joint Committee 0.310074 with or without 0.33621 locally advanced 0.381657 T2 nasopharyngeal carcinoma 0.309762 nasopharyngeal carcinoma treated 0.317452 node-positive nasopharyngeal carcinoma 0.317088 Cancer Study Group 0.311102 induction chemotherapy 0.311013	CLICK HERE
1882	National Cancer Institute	Html	es	Tratamiento del ependimoma infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del ependimoma infantil.	Hielscher T 0.367784 Grado III 0.497368 prognostic factors 0.418199 Merchant TE 0.351136 Brain Tumor Registry 0.358501 Korshunov A 0.366815 spinal cord ependymomas 0.397087 posterior fossa ependymoma 0.679456 C11orf95-RELA fusions drive 0.339744 líquido cefalorraquídeo 0.413022 infratentorial childhood ependymomas 0.36981 localized ependymoma 0.366693 Radiat Oncol Biol 0.730863 gen rela 0.348774 Pediatric Brain Tumor 0.377851 central nervous system 0.408683 patients with 0.480087 paediatric ependymoma 0.378048 pediatric intracranial ependymoma 0.417211 Acta Neuropathol 0.362477 Mack SC 0.397938 Retrospective Multicohort Analysis 0.345199 cuarto ventrículo 0.34367 United States 0.381387 childhood ependymoma 0.440498	intracranial ependymoma 0.9229 Neuro Oncol 0.422395 pediatric patients with 0.359423 radioterapia posoperatoria 0.479259 Pediatr Blood Cancer 0.435451 myxopapillary ependymoma 0.400108 spinal cord 0.397509 supratentorial ependymoma 0.360521 C11orf95-RELA fusions 0.341174 ependymoma patients with 0.34014 infantil recién 0.356568 Clin Oncol 0.43496 childhood intracranial ependymoma 0.4276 sistema nervioso central 0.476331 with intracranial ependymoma 0.449085 Oncol Biol Phys 0.751374 brain tumor 0.436772 Witt H 0.430118 Grado II 0.78433 patients with localized 0.344179 Central Brain Tumor 0.357242 ependimoma infantil grupo 0.387504 Childs Nerv Syst 0.378828 Brain Tumor Consortium 0.35913	CLICK HERE
1936	National Cancer Institute	Html	es	Tratamiento de los tumores extracraneales de células germinativas en la niñez (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores extracraneales de células germinativas en la niñez.	siguientes procedimientos 0.383487 células madre 0.843271 posibles factores 0.316699 estadio iv 0.881585 adultos jóvenes 0.38604 siguientes áreas 0.332444 afecciones quizás 0.318252 Diferentes tipos 0.319717 Estadio IIIC 0.352194 siguientes tipos 0.320718 tumores mixtos 0.42367 rayos x 0.344377 estadio ib 0.390154 niño ayuda 0.314653 efectos tardíos 0.453508 PDQ Efectos tardíos 0.33586 teratomas benignos 0.329972 cm).estadio iiia 0.314756 tarde.ampliar ecografía 0.317174 National Cancer Institute 0.311618 tumores benignos 0.431931 IRMN).Ampliar Imágenes 0.3138 estadio iic.estadio iia 0.359243 siguientes lugares 0.327905	germinomas.Los disgerminomas 0.320088 siguientes riesgos 0.31126 tratamiento quizás 0.335386 Instituto Nacional 0.320237 PDQ Tratamiento 0.64104 células germinativas.Teratomas 0.463139 estadio iiia 0.352727 efectos tardíos quizás 0.32327 células germinativas mixtos 0.491909 siguientes marcadores 0.329439 siguientes signos 0.328509 nuevos tipos 0.313861 saco vitelino 0.360548 partes distantes 0.338927 coriónica humana beta 0.527277 Physician Data Query 0.340834 sistema nervioso central 0.331507 estadio iii 0.993051 germinomas.Los tumores 0.426016 tumoresde células 0.36494 estadio ic.estadio ia 0.359207 siguientes pruebas 0.327352 marcadores tumorales.La 0.319745	CLICK HERE
1966	National Cancer Institute	Html	es	Tratamiento del cáncer de labio y de cavidad oral (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de labio y de cavidad oral.	medicamentos retinoides 0.568081 siguientes procedimientos 0.97932 siguientes elementos 0.624752 estadio ii 0.723086 rayos x 0.572217 pequeñas marcas 0.537003 estadio ivc 0.583451 necesarios implantes 0.546577 siguientes riesgos 0.500736 malla ayuda 0.53799 Instituto Nacional 0.536147 área pequeña detrás 0.642422 presente sección 0.536306	partes distantes 0.555475 Physician Data Query 0.531283 estadio iii 0.581263 libre uso 0.500877 radioterapia hiperfraccionada 0.899395 cáncer.ampliar radioterapia 0.670655 Cancer Institute 0.499502 siguientes enlaces 0.516515 siguientes pruebas 0.617318 Dientes flojos 0.587562 pequeño espejo 0.576408 siguientes estadios 0.58645	CLICK HERE
3433	National Cancer Institute	Html	es	Plantas crucíferas y la prevención del cáncer	Hoja informativa que resume los resultados de estudios sobre las plantas crucíferas y el cáncer. Incluye una lista de plantas crucíferas y las guías alimenticias recomendadas para el consumo de verduras.	lung-cancer risk 0.307792 vegetable consumption 0.312833 Mehta RG 0.302691 risk only 0.307938 Breast Cancer Detection 0.318522 Crowley-Nowick P 0.30257 P1 polymorphisms 0.302724 from case-control studies 0.304583 Appleby P 0.302596 vitaminas c 0.302699 Estados Unidos 0.329183 American Journal 0.315502 enzima glutatión 0.302759 phytochemicals derived from 0.304521 PubMed Abstract 0.825953 Verhoeven DT 0.30258 Eggleston IM 0.302576 Drug Metabolism Reviews 0.304253 International Journal 0.303618 investigation into cancer 0.31721 cohort study 0.390686 Health Professionals 0.302655 S-transferase M1 0.306619 multiethnic case-control study 0.310202 plantas crucíferas 0.972584	Países Bajos 0.321735 mayores cantidades 0.306865 alto consumo 0.304048 Project follow-up cohort 0.305167 Multiethnic Cohort Study 0.310843 sustancias llamadas glucosinolatos 0.304891 among men 0.30319 Murillo G 0.302582 prospective cohort study 0.312078 lower lung 0.303353 fruit consumption 0.320125 Clinical Nutrition 0.310798 rectal cancer 0.307152 Ziegler RG 0.302564 breast cancer 0.357017 Goldbohm RA 0.316028 Cancer Institute 0.343115 género brassica 0.30299 prospective study 0.373394 Bajos—el Netherlands Cohort 0.307492 glutathione s-transferase 0.312115 vegetable intakes 0.305276 Netherlands Cohort Study 0.345768 glutathione s-transferase polymorphisms 0.30497	CLICK HERE
3600	National Cancer Institute	Html	en	NCI-COG Pediatric MATCH	In this precision medicine clinical trial, children and adolescents with advanced cancers whose tumors have certain genetic mutations will be treated with drugs that are matched to those mutations.	histiocytoses—whose cancer 0.377277 genetic makeup 0.401588 university medical centers 0.467884 brain tumors 0.440585 blood sample 0.480719 clinical trials 0.534239 additional genetic testing 0.511528 patients 0.666156 new treatment arms 0.480309 visit NCI 0.372109 solid tumors 0.469802 open treatment arms 0.478804 tumor sample 0.358797 Children’s Oncology 0.616646 genomic sequencing 0.508758 pediatric oncologist 0.373126 genetic changes 0.973154 precision medicine 0.370826 Hereditary genetic changes 0.524899 certain drugs 0.381989 screening step 0.630676 laboratory method 0.368599 Pediatric MATCH 0.671874 NCI-COG Pediatric MATCH 0.543169 specific targeted drugs 0.540831	nationwide cancer treatment 0.58381 cancer cells 0.393101 Cancer Information Service 0.476816 pediatric patients 0.406357 genetic counseling 0.384583 Clinical Trials Network 0.452506 enrollment steps 0.358937 treatment arm 0.797992 pediatric cancers 0.526249 experimental drugs 0.379128 genetic change 0.798918 study drugs 0.381585 contact NCI 0.380025 health insurance plans 0.447587 specific genetic changes 0.498204 experimental treatment 0.509457 certain genetic changes 0.509656 cancer centers 0.372633 cancer site 0.501146 clinical trials search 0.454345 tumors 0.675099 cancer information specialists 0.479605 Oncology Group 0.642399 standard treatment 0.375977	CLICK HERE
17222	National Cancer Institute	Html	en	Tumor DNA Sequencing in Cancer Treatment	Tumor DNA sequencing (also called genetic profiling or genetic testing) is a test to identify DNA changes in a patient’s cancer. In some cases, this information can help determine a treatment plan.	unique DNA changes 0.327494 health care provider 0.21495 lung tumor 0.253938 tumor sequencing 0.343527 specific genetic alterations 0.302101 healthy cells 0.230873 Multigene panel tests 0.208409 health care team 0.2107 frequently used sequencing 0.320207 hereditary cancer syndromes 0.221971 health care providers 0.211937 whole-genome sequencing 0.314537 cancer types 0.228448 DNA changes 0.331071 patient care 0.205253 targeted sequencing tests 0.342426 broad tumor DNA 0.375946 heterogeneous tumor 0.233471 DNA sequencing tests 0.507176 precision medicine 0.222532 single cancer type 0.228039 lung cancer cells 0.3596 treatment 0.286045 precision medicine trials 0.205063	DNA alteration 0.251455 NCI-COG Pediatric MATCH 0.207207 inherited genetic alteration 0.228682 DNA sequence 0.253453 cancer cells 0.454035 unique genetic alterations 0.280668 sequencing tests cost 0.308627 EGFR mutation 0.209321 Broad DNA sequencing 0.411749 cancer-causing DNA changes 0.297683 way cells function 0.250384 tumor dna 0.91525 tumor dna sequencing 0.748819 DNA sequencer 0.254089 Clinical tumor DNA 0.406068 health care 0.275099 DNA sequencing test 0.405098 mRNA expression test 0.209986 breast cancer 0.203535 genetic alterations 0.703142 cancer 0.512553 standard treatment 0.204466 whole-exome sequencing 0.314247 quantitative mRNA test 0.208612	CLICK HERE